Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02216409
Title Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Forty Seven, Inc.
Indications

lymphoma

Advanced Solid Tumor

Therapies

Hu5F9-G4

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.